Clinical trials
Withdrawn Phase 2 Liver Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Allan Tsung | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Medical University of South Carolina | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Chicago | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 9 |
| Carcinoma, Hepatocellular | 5 |
| Neoplasm Metastasis | 2 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Duodenal Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.